Healthcare / Drug Manufacturers - Specialty & GenericUpdated 2026-05-10 22:07 UTC

OSL/PHO stock hub

OSL/PHO has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

Browse stocks

OSL/PHOis not in this month’s coverageGet our monthly research letter — no spam

Fair value midpoint

n/a

Fair value pending

Upside to midpoint

n/a

Based on latest report

Confidence

n/a

Data quality and model convergence

Market cap

1.7B

Oslo Børs

Market data

Live price

Current market quote for this ticker.

Current price

OSL/PHO

In the news

Latest news · OSL/PHO

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/E23.7

P25 n/aP50 n/aP75 n/a

Trailing P/E20.3

P25 n/aP50 n/aP75 n/a

ROE16.1

P25 n/aP50 n/aP75 n/a

ROIC32.1

P25 n/aP50 n/aP75 n/a

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Indicator catalog

All OSL/PHO market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

219

Groups with data

Currency

NOK

Showing 219 of 219 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Country	Norway
Country code	NO
Employees	102
Employees Change	1%
Employees Change Percent	0.99
Enterprise value	NOK 1.5B
Exchange	Oslo Børs
Financial currency	NOK
First seen	2026-05-10
Industry	Drug Manufacturers - Specialty & Generic
Isin	NO0010000045
Last refreshed	2026-05-10
Market cap	NOK 1.7B
Price	NOK 64.1
Price currency	NOK
Rev Per Employee	6,718,520x
Sector	Healthcare
Sic	2834
Symbol	osl/PHO
Website	https://www.photocure.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	4.94%
EV Earnings	17.94x
EV/EBIT	12.05x
EV/EBITDA	9.75x
EV/FCF	902.09x
EV/Sales	2.25x
FCF yield	0.1%
Forward P/E	23.74x
P/B ratio	2.95x
P/E ratio	20.28x
P/S ratio	2.54x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT Margin	18.68%
EBITDA Margin	22.27%
FCF margin	0.25%
Gross margin	93.57%
Gross Profit	NOK 628.7M
Gross Profit Growth	25.59%
Gross Profit Growth Q	118.82%
Gross Profit Growth3 Y	16.79%
Gross Profit Growth5 Y	18.22%
Net Income	NOK 84.3M
Net Income Growth	3,843.55%
Net Income Growth Quarters	1%
Net Income Growth Years	1%
Net Income Growth5 Y	51.77%
Pretax Margin	15.2%
Profit Margin	12.55%
Profit Per Employee	NOK 843,130
ROA	10.5
Roa5y	-0.08
ROCE	18.19
ROE	16.06
Roe5y	-4.36
ROIC	32.13
Roic5y	-4.87

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr10y	4.03%
Cagr15y	2.57%
Cagr1y	22.35%
Cagr20y	2.7%
Cagr3y	5.88%
Cagr5y	-13.39%
EPS Growth	3,895.6
EPS Growth Quarters	1
EPS Growth Years	1
EPS Growth5 Y	50.78
FCF Growth	-97.15%
FCF Growth3 Y	-33.56%
FCF Growth5 Y	-29.07%
OCF Growth	-60.83%
OCF Growth Q	-80.98%
OCF Growth3 Y	37.28%
OCF Growth5 Y	21.58%
Revenue Growth	26.13x
Revenue Growth Q	111.12x
Revenue Growth Quarters	1x
Revenue Growth Years	5x
Revenue Growth3 Y	17.16x
Revenue Growth5 Y	18.32x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	NOK 0.9
Assets	NOK 786M
Cash	NOK 192.7M
Current Assets	NOK 460.4M
Current Liabilities	NOK 96M
Equity	NOK 577.9M
Interest Coverage	3.45
Liabilities	NOK 208.1M
Long Term Assets	NOK 325.6M
Long Term Liabilities	NOK 112.1M
Net Cash	NOK 192.7M
Net Cash By Market Cap	NOK 11.3
Net Cash Growth	-25.76%
Net Debt EBITDA	NOK -1.29
Net Debt Equity	NOK -0.33
Net Debt FCF	NOK -115
Tangible Book Value	NOK 358.9M
Tangible Book Value Per Share	NOK 13.51
WACC	6.41

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	4.79
Inventory Turnover	1.11
Net Working Capital	NOK 171.7M
Quick ratio	4.38
Working Capital	NOK 364.4M
Working Capital Turnover	NOK 2.06

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	1.4%
Dividend per share	NOK 0
Last Dividend	NOK 2

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
10Y total return	48.38%
1Y total return	22.33%
200-day SMA	63.43
3Y total return	18.7%
50-day SMA	65.65
50-day SMA vs 200-day SMA	50over200
5Y total return	-51.25%
All Time High	184
All Time High Change	-65.16%
All Time High Date	2000-03-09
All Time Low	17.7
All Time Low Change	262.15%
All Time Low Date	2014-11-04
ATR	3.01
Beta	0.39
Beta1y	0.23
Beta2y	0.42
Ch YTD	-10.22
High	66.8
High52	79.8
High52 Date	2026-01-15
High52ch	-19.67%
Low	63.8
Low52	48.5
Low52 Date	2025-05-08
Low52ch	32.17%
Ma50ch	-2.36%
Price vs 200-day SMA	1.06%
RSI	45.27
RSI Monthly	51.33
RSI Weekly	49.36
Sharpe ratio	0.59x
Sortino ratio	1.05
Total Return	1.4%
Tr YTD	-10.22
Tr15y	46.31%
Tr1m	10.33%
Tr1w	-5.6%
Tr3m	-1.84%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Operating Income	NOK 125.5M
Operating Income Growth	791.6
Operating margin	18.68

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	19,953,433%
Net Borrowing	5,843,000
Shares Insiders	2.93%
Shares Institutions	61.87%
Shares Out	26,606,672
Shares Qo Q	0.84%
Shares Yo Y	-1.4%

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	NOK -16.6M
Average Volume	110,162.75x
Bv Per Share	21.75
CAPEX	NOK -26.7M
Ch10y	48.38
Ch15y	38.45
Ch1m	10.33
Ch1w	-5.6
Ch1y	22.33
Ch20y	49.07
Ch3m	-1.84
Ch3y	18.7
Ch5y	-51.25
Ch6m	11.67
Change	-3.17%
Change From Open	-4.04
Close	66.2
Days Gap	0.91
Depreciation Amortization	24,103,000
Dollar Volume	4,198,229.5
Earnings Date	2026-04-13
EBIT	NOK 125.5M
EBITDA	NOK 149.6M
EPS	NOK 3.16
F Score	5
FCF	NOK 1.7M
FCF EV Yield	0.11x
FCF Per Share	NOK 0.06
Financing CF	-50,709,000
Fiscal Year End	December
Founded	1,993
Goodwill	144,000,000
Graham Number	39.33278
Graham Upside	-38.64
Income Tax	NOK 17.8M
Investing CF	-44,513,000
Is Primary Listing	1
Last Earnings Date	2026-04-13
Last Report Date	2026-03-31
Lynch Fair Value	NOK 79.02
Lynch Upside	23.28
Ma150	64.17
Ma150ch	-0.1%
Ma20	67.89
Ma20ch	-5.58%
Net CF	-66,848,000
Next Earnings Date	2026-07-29
Open	66.8
P FCF Ratio	1,017
P OCF Ratio	60.11
Position In Range	10
Ppne	47,796,000
Price Date	2026-05-08
Price EBITDA	NOK 11.4
Ptbv Ratio	4.75
Relative Volume	0.6x
Revenue	671,852,000x
SBC By Revenue	2.72x
Share Based Comp	18,292,000
Tax By Revenue	2.65x
Tax Rate	17.43%
Tr20y	70.47%
Tr6m	11.67%
Volume	65,495

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

n/a

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

n/a

Business quality stays separate from stock attractiveness.

Forward P/E

n/a

Valuation uses the full report model stack, not a single multiple.

Next action

Research pending

Final action steps are kept in the recommendation tab.

Income

Does OSL/PHO pay a dividend?

Capital-return profile for this ticker.

Performance

OSL/PHO stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

Ownership

Who owns OSL/PHO?

Insider, institutional, and short-interest positioning.

Institutional ownership

+61.9%

Share of float held by funds and institutions

Insider ownership

+2.9%

Stake held by company insiders. Higher generally signals alignment.

Short interest

n/a

Float sold short by bearish positioning

Y/Y dilution

-1.4%

Negative means the company is buying back shares.

Technical

OSL/PHO momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

45.3

Neutral momentum band

Price vs 200-day MA

+1.1%

50/200-day relationship not available

Beta (5Y)

0.39

Less volatile than the market

Sharpe ratio

0.59

Risk-adjusted return — higher is better; >1.0 is solid.

Questions

About OSL/PHO

Hub-level FAQ points readers to the deeper analysis pages.

What is the current osl/PHO stock rating?

osl/PHO is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full osl/PHO analysis?

The full report lives at /stocks/osl/PHO/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for osl/PHO?

The latest report frames osl/PHO around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the osl/PHO page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.